Diamond Biofund is committed to fulfilling its corporate social responsibility by protecting the basic human rights of all employees, customers, and stakeholders. The company adheres to international human rights conventions such as the “Universal Declaration of Human Rights (UDHR),” “UN Guiding Principles on Business and Human Rights (UNGPs),” “UN Global Compact (UNGC),” and the “International Labour Organization (ILO),” and complies with labor laws in the regions where it operates. The company has formulated human rights policies and specific management plans.
To implement labor rights policies within its operations, Diamond Biofund provides education and training during onboarding and arranges at least one human rights-related training session annually, covering equality and non-discrimination requirements. In 2025, the company held sexual harassment and workplace violations prevention training in November, requiring all employees to participate. These courses deepen employees’ understanding of workplace bullying and sexual harassment and inform them about the company’s grievance mechanisms, providing a friendly work environment. To ensure compliance with legal regulations, all employees are required to take an exam, with a passing score of 80 or above.
Diamond Biofund values all opinions and ideas and strives to provide open and transparent communication channels. Internally, the company has set up complaint hotlines and an email address, holds quarterly labor-management meetings, conducts interviews with new employees after their probationary period, and conducts exit interviews. Employees can use various channels to express concerns about organizational systems and the work environment. The company’s website offers contact platforms for expressing opinions to regulatory authorities, shareholders/investors, investee companies, employees, communities, and the media. Moreover, upholding a core culture of continuous improvement, the company conducts annual employee feedback surveys. Through anonymous surveys, employees can provide suggestions for improving work processes and systems. After compiling the survey results, the relevant departments use them to continuously optimize processes and systems. In 2025, no complaints were received.
Internal Communication and Grievance Channels
Communication and Grievance Email: hr@diamondbiofund.com
Management and Mitigation Measures, Compensation Measures, and 2025 Implementation Results
(As Diamond Biofund has only one operational site, all management and mitigation measures, compensation measures, and 2025 implementation outcomes pertain to this site.)
|
Human rights topic |
Management measures and mitigation measures |
Compensation measures |
2025 implementation results |
|
Safe and Healthy Work Environment |
|
|
|
|
Wage Equality
|
|
|
|
|
Freedom of Assembly and Expression
|
|
|
|
|
Prohibition of Child Labor |
|
|
|
|
Reasonable Working Hours |
|
|
|
|
Prohibition of Forced Labor
|
|
|
|
|
Prohibition of Human Trafficking
|
|
|
|
|
Family Life Rights
|
|
|
|
|
Gender Equality and Sexual Harassment Prevention
|
|
|
|
|
Workplace Discrimination and Bullying |
|
|
|
|
Environmental Pollution
|
|
|
|
|
Personal Data Protection and Privacy |
|
|
|
醣基生醫股份有限公司
2017年9月27日登錄興櫃市場交易 (6586:TT)
公司所在地
台北,台灣
公司設立日期
2013
登錄公開市場
2017
公司官網
https://www.chopharma.com/cn/index.html